What is Hemophagocytic Lymphohistiocytosis (HLH)?
HLH is a life-threatening hyperinflammatory syndrome caused by uncontrolled activation of macrophages and cytotoxic T cells, leading to a cytokine storm that results in end-organ damage and death without aggressive immunosuppressive treatment. 1
Core Pathophysiology
HLH represents an aberrant immune response where the body's cytotoxic immune cells (CD8 T cells and natural killer cells) become excessively activated but fail to effectively eliminate their targets. This leads to:
- Cellular hyperactivation with rampant cytokine secretion
- Widespread systemic inflammation affecting multiple organ systems
- Rapid progression to multiorgan failure if untreated 2
The syndrome is fundamentally characterized by an excessive but ineffective immune response that paradoxically causes more harm than the original trigger 2.
Two Major Forms
Primary (Genetic) HLH
- Most common in children
- Caused by bi-allelic germline mutations in genes affecting cytotoxic granule function (PRF1, UNC13D, STX11, STXBP2)
- Results in markedly reduced or absent CD8 T-cell and NK-cell-mediated killing
- Can occur in adolescents and young adults 1, 2
Secondary (Acquired) HLH
- Most common in adults
- Triggered by strong immunological stimuli:
- Infections (viral, bacterial, fungal)
- Malignancies (especially lymphomas)
- Autoimmune/autoinflammatory disorders (termed Macrophage Activation Syndrome or MAS-HLH in this context)
- Patients generally lack bi-allelic mutations in primary HLH genes 1, 2
Clinical Presentation
The syndrome manifests as a sepsis-like picture that can be indistinguishable from sepsis or multiple organ dysfunction syndrome, creating a major diagnostic challenge 1.
Key clinical features include:
- Persistent high-grade fever
- Hepatosplenomegaly (enlarged liver and spleen)
- Cytopenias (low blood cell counts affecting multiple lineages)
- Liver dysfunction
- Coagulopathy (bleeding disorders)
- Rapid progression to terminal multiorgan failure 1, 3
Critical Diagnostic Pitfall
Early recognition is paramount because HLH can prevent irreversible organ damage and death. 1 The condition is frequently missed because:
- It mimics sepsis clinically
- The HLH-2004 diagnostic criteria were developed for children and are not validated for adults 1
- Patients may present across multiple specialties (hematology/oncology, infectious diseases, rheumatology, intensive care, emergency medicine) 1
Why This Matters for Mortality and Morbidity
Without treatment directed at suppressing the overactive immune system, HLH is fatal. 2 The hyperinflammation causes:
- End-organ tissue damage from the cytokine storm
- High mortality rates in untreated patients 4
- Irreversible organ damage if diagnosis is delayed 1
The key to improving outcomes is maintaining high clinical suspicion in any patient presenting with unexplained fever, cytopenias, hepatosplenomegaly, and hyperferritinemia—particularly when these occur in the context of known triggers like infection, malignancy, or autoimmune disease 1, 4.
Age-Specific Considerations
Adults and children have different disease presentations, triggers, organ reserve, and fitness levels. 1 Transferring pediatric treatment protocols (HLH-94, HLH-2004) directly to adults may result in:
- Overtreatment and unnecessary toxicity
- Need for dose reductions and individualized treatment duration
- Requirement for age-dependent modified diagnostic approaches 1
This distinction is critical because secondary HLH in adults often requires treatment of the underlying trigger (infection, malignancy, autoimmune disease) in addition to immunosuppression, whereas primary HLH in children may ultimately require hematopoietic stem cell transplantation 1, 2.